Connection

THOMAS MONATH to Aedes

This is a "connection" page, showing publications THOMAS MONATH has written about Aedes.
Connection Strength

1.170
  1. Experimental infection of Culex annulirostris, Culex gelidus, and Aedes vigilax with a yellow fever/Japanese encephalitis virus vaccine chimera (ChimeriVax-JE). Am J Trop Med Hyg. 2006 Oct; 75(4):659-63.
    View in: PubMed
    Score: 0.251
  2. Responding to the threat of urban yellow fever outbreaks. Lancet Infect Dis. 2017 03; 17(3):248-250.
    View in: PubMed
    Score: 0.128
  3. Aedes albopictus in the United States: rapid spread of a potential disease vector. J Am Mosq Control Assoc. 1988 Sep; 4(3):356-61.
    View in: PubMed
    Score: 0.072
  4. Growth characteristics of ChimeriVax-Den vaccine viruses in Aedes aegypti and Aedes albopictus from Thailand. Am J Trop Med Hyg. 2006 Nov; 75(5):986-93.
    View in: PubMed
    Score: 0.063
  5. Aedes albopictus, an exotic mosquito vector in the United States. Ann Intern Med. 1986 Sep; 105(3):449-51.
    View in: PubMed
    Score: 0.062
  6. Replication of chimeric yellow fever virus-dengue serotype 1-4 virus vaccine strains in dendritic and hepatic cells. Am J Trop Med Hyg. 2005 Jan; 72(1):74-81.
    View in: PubMed
    Score: 0.056
  7. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys. J Virol. 2004 Sep; 78(18):9998-10008.
    View in: PubMed
    Score: 0.054
  8. Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction. Am J Trop Med Hyg. 2004 Jan; 70(1):89-97.
    View in: PubMed
    Score: 0.052
  9. Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes. Med Vet Entomol. 2003 Sep; 17(3):235-43.
    View in: PubMed
    Score: 0.051
  10. Growth characteristics of ChimeriVax-DEN2 vaccine virus in Aedes aegypti and Aedes albopictus mosquitoes. Am J Trop Med Hyg. 2002 Sep; 67(3):260-5.
    View in: PubMed
    Score: 0.047
  11. Yellow fever: an update. Lancet Infect Dis. 2001 Aug; 1(1):11-20.
    View in: PubMed
    Score: 0.044
  12. Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF/JE SA14--14--2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes. Am J Trop Med Hyg. 2000 Apr; 62(4):480-4.
    View in: PubMed
    Score: 0.040
  13. Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector species. Hum Vaccin Immunother. 2018 04 03; 14(4):994-1002.
    View in: PubMed
    Score: 0.034
  14. Epidemic arboviral diseases: priorities for research and public health. Lancet Infect Dis. 2017 03; 17(3):e101-e106.
    View in: PubMed
    Score: 0.032
  15. Dengue: the risk to developed and developing countries. Proc Natl Acad Sci U S A. 1994 Mar 29; 91(7):2395-400.
    View in: PubMed
    Score: 0.026
  16. Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus. Infect Genet Evol. 2013 Oct; 19:292-311.
    View in: PubMed
    Score: 0.025
  17. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria. Am J Trop Med Hyg. 1993 Feb; 48(2):274-99.
    View in: PubMed
    Score: 0.024
  18. Epidemic yellow fever caused by an incompetent mosquito vector. Trop Med Parasitol. 1989 Dec; 40(4):396-9.
    View in: PubMed
    Score: 0.020
  19. Genetic variation and microevolution of dengue 2 virus in Southeast Asia. Virology. 1989 Oct; 172(2):523-35.
    View in: PubMed
    Score: 0.019
  20. Multisite monoclonal immunoassay for dengue viruses: detection of viraemic human sera and interference by heterologous antibody. J Gen Virol. 1986 Apr; 67 ( Pt 4):639-50.
    View in: PubMed
    Score: 0.015
  21. [Yellow fever in Senegal from 1976 to 1980 (author's transl)]. Med Trop (Mars). 1981 Jan-Feb; 41(1):45-51.
    View in: PubMed
    Score: 0.011
  22. Yellow fever in the Gambia, 1978--1979: epidemiologic aspects with observations on the occurrence of orungo virus infections. Am J Trop Med Hyg. 1980 Sep; 29(5):912-28.
    View in: PubMed
    Score: 0.010
  23. Yellow fever in the Gambia, 1978--1979: entomological aspects and epidemiological correlations. Am J Trop Med Hyg. 1980 Sep; 29(5):929-40.
    View in: PubMed
    Score: 0.010
  24. Urban yellow fever epidemic in western Nigeria, 1987. Trans R Soc Trop Med Hyg. 1989 May-Jun; 83(3):401-6.
    View in: PubMed
    Score: 0.005
  25. Epidemic yellow fever in eastern Nigeria, 1986. Lancet. 1988 Mar 19; 1(8586):630-3.
    View in: PubMed
    Score: 0.004
  26. Arbovirus isolations from mosquitoes collected during and after the 1982-1983 epizootic of western equine encephalitis in Argentina. Am J Trop Med Hyg. 1987 Jan; 36(1):107-13.
    View in: PubMed
    Score: 0.004
  27. Genetic heterogeneity of yellow fever virus strains from Africa and the Americas. J Gen Virol. 1986 Jan; 67 ( Pt 1):209-13.
    View in: PubMed
    Score: 0.004
  28. Arbovirus investigations in Argentina, 1977-1980. II. Arthropod collections and virus isolations from Argentine mosquitoes. Am J Trop Med Hyg. 1985 Sep; 34(5):945-55.
    View in: PubMed
    Score: 0.004
  29. Arbovirus investigations in Argentina, 1977-1980. III. Identification and characterization of viruses isolated, including new subtypes of western and Venezuelan equine encephalitis viruses and four new bunyaviruses (Las Maloyas, Resistencia, Barranqueras, and Antequera). Am J Trop Med Hyg. 1985 Sep; 34(5):956-65.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.